Curr Ther Res Clin Exp. 2015 Jun 06;77:63-5. doi: 10.1016/j.curtheres.2015.06.001. eCollection 2015 Dec.
A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study.
Current therapeutic research, clinical and experimental
Jurij Hanžel, Žiga Piletič, Martina Turk, Barbara Eržen, Mišo Šabovič
Affiliations
Affiliations
- Department of Vascular Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
PMID: 26199676
PMCID: PMC4506977 DOI: 10.1016/j.curtheres.2015.06.001
Abstract
BACKGROUND: Despite optimum treatment, patients who experience myocardial infarction are still at high risk for future events.
OBJECTIVE: We evaluated the effect of 30 days of treatment with combination of low, subtherapeutic doses of fluvastatin and valsartan on arterial stiffness in patients after myocardial infarction, a therapy that has not been used yet.
METHODS: Fourteen male patients with a history of myocardial infarction were enrolled into a pilot double-blind randomized controlled study. They were allocated to receive 10 mg fluvastatin and 20 mg valsartan or placebo for 30 days in addition to their regular pharmacotherapy. Carotid-femoral pulse wave velocity was measured on inclusion, after 30 days, and after 3 months.
RESULTS: Mean (SD) carotid-femoral pulse wave velocity decreased significantly in the treatment group after 30 days and persisted at lower values after 3 months (from 8.4 [1.5] m/sec to 7.3 [1.1] m/sec to 7.2 [0.8] m/sec; P < 0.05). The 95% CI for decrease after 30 days in the treatment group was 0.5-1.6. Only nonsignificant changes were observed in the control group. Serum lipid levels and arterial blood pressure did not change significantly in any group.
CONCLUSIONS: The treatment resulted in a significant and sustained improvement of arterial stiffness in male patients with a history of myocardial infarction, which highlights the need for further study of this new approach.
Keywords: arterial stiffness; fluvastatin; low doses; myocardial infarction; valsartan
References
- ScientificWorldJournal. 2013 Oct 30;2013:792693 - PubMed
- J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):177-83 - PubMed
- Heart Vessels. 2009 Sep;24(5):340-6 - PubMed
- Circulation. 2013 Jun 25;127(25):2477-84 - PubMed
- Diab Vasc Dis Res. 2013 Sep;10(5):420-5 - PubMed
- Eur J Intern Med. 2012 Apr;23(3):261-6 - PubMed
- Eur Heart J. 2006 Nov;27(21):2588-605 - PubMed
- Circulation. 2014 Jan 21;129(3):e28-e292 - PubMed
- Hypertension. 2004 Nov;44(5):758-63 - PubMed
- Hypertension. 2014 Jan;63(1):105-11 - PubMed
- Am J Hypertens. 2013 May;26(5):608-16 - PubMed
- Clin Invest Med. 2009 Dec 01;32(6):E238 - PubMed
- J Cardiovasc Pharmacol. 2002 Jul;40(1):28-34 - PubMed
- J Hypertens. 2012 Mar;30(3):445-8 - PubMed
- J Hypertens. 2011 Jun;29(6):1034-42 - PubMed
Publication Types